Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Рак желудка – современные тенденции в диагностике и лечении на примере опыта российских клиник по данным исследования REGATE
Рак желудка – современные тенденции в диагностике и лечении на примере опыта российских клиник по данным исследования REGATE
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Parkin D, Bray F, Ferlay J, Pisani D. Global cancer statistics. Cancer J Clin 2005; 55: 74–108.
2. Ter-Ovanesov M, Bang Y et al. REGATE: What happens to gastric cancer treatment in the real world? Ann Onc 2006; 17 (Suppl. 6): 013.
3. Bang YJ, Ter-Ovanesov M, Wu CW et al. REGATE: Planned and actual strategies of gastric cancer treatment. ASCO GI 2007; abs 60.
4. Solcia E, Fiocca R, Luinetti O et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter Pylori gastritis through different gene involvement. Am J Surg Pathol 1996; 20 (Suppl. 1): S8–22.
5. Nishi M, Ichikawa H, Nakajima T et al. Gastric cancer. Springer-Verlag, 1993.
6. Japanese Classification of Gastric Cancer – 2nd English Edition. Japanese Gastric Cancer Association. Gastric Cancer 1998; 1: 10–24.
7. UICC & AJCC Cancer Staging Manual, 6th ed. Lippincott-Raven Publs, 2002.
8. Aiko T, Sasako M. For General Rules Committee of the Japanese Gastric Cancer Association. The new Japanese classification of Gastric Carcinoma: points to be revised. Gastric Cancer 1998; 1: 25–30.
9. Hermanek P. The second English edition of the Japanese Classification of Gastric Carcinoma. A Western commentary. Gastric Cancer 1999; 2: 79–82.
10. Sasako M, Aiko T. Reply to Professor Hermanek’s comments on the new Japanese classification of gastric carcinoma. Gastric Cancer 1999; 2: 83–5.
11. Maruyama K, Gunvin P, Kinoshita T et al. Lymph node metastasis of gastric cancer: general patterns in 1931 patients. Ann Surg 1989; 210: 596–602.
12. Takagane A, Terishima M, Abe K et al. Clinicopathological studies on skip metastasis of lymph nodes in patients with respectable gastric cancer. J Iwate Med Associat 1998; 50: 331–6.
13. Aiko T, Sasako M. For General Rules Committee of the Japanese Gastric Cancer Association. The new Japanese classification of Gastric Carcinoma: points to be revised. Gastric Cancer 1998; 1: 25–30.
14. Тер-Ованесов М.Д. Факторы прогноза хирургического лечения рака проксимального отдела желудка. Дис. ... д-ра мед. наук. М., 2007.
15. Hartgrink HH, van de Velde CJ, Putter H et al. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomized FAMTX trial. Eur J Surg Oncol 2004; 30: 643–9.
16. David Cunningham, William H Allum, Sally P. Stenning et al. for the MAGIC Trial: Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer NEJM, 2006; 355: 11–20.
17. Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725–30.
18. Sano T, Sasako M. For the Gastric Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG). Randomised controlled trial to evaluate para-aortic lymphadenectomy for gastric cancer (JCOG 9501). IVth International Gastric Cancer Congress, Abstructs, S 45: p. 663.
19. Sasako M. Extent of Lymphadenectomy in gastric Cancer: Have we Finally come to a Consensus? Gastrointestinal Cancer Symposium: multidisciplinary approaches to the prevention, diagnosis and therapy of GI Cancer, 2007; 39–41.
20. Ross P, Nicolson M, Cunningham D et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002; 20: 1996–2004.
2. Ter-Ovanesov M, Bang Y et al. REGATE: What happens to gastric cancer treatment in the real world? Ann Onc 2006; 17 (Suppl. 6): 013.
3. Bang YJ, Ter-Ovanesov M, Wu CW et al. REGATE: Planned and actual strategies of gastric cancer treatment. ASCO GI 2007; abs 60.
4. Solcia E, Fiocca R, Luinetti O et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter Pylori gastritis through different gene involvement. Am J Surg Pathol 1996; 20 (Suppl. 1): S8–22.
5. Nishi M, Ichikawa H, Nakajima T et al. Gastric cancer. Springer-Verlag, 1993.
6. Japanese Classification of Gastric Cancer – 2nd English Edition. Japanese Gastric Cancer Association. Gastric Cancer 1998; 1: 10–24.
7. UICC & AJCC Cancer Staging Manual, 6th ed. Lippincott-Raven Publs, 2002.
8. Aiko T, Sasako M. For General Rules Committee of the Japanese Gastric Cancer Association. The new Japanese classification of Gastric Carcinoma: points to be revised. Gastric Cancer 1998; 1: 25–30.
9. Hermanek P. The second English edition of the Japanese Classification of Gastric Carcinoma. A Western commentary. Gastric Cancer 1999; 2: 79–82.
10. Sasako M, Aiko T. Reply to Professor Hermanek’s comments on the new Japanese classification of gastric carcinoma. Gastric Cancer 1999; 2: 83–5.
11. Maruyama K, Gunvin P, Kinoshita T et al. Lymph node metastasis of gastric cancer: general patterns in 1931 patients. Ann Surg 1989; 210: 596–602.
12. Takagane A, Terishima M, Abe K et al. Clinicopathological studies on skip metastasis of lymph nodes in patients with respectable gastric cancer. J Iwate Med Associat 1998; 50: 331–6.
13. Aiko T, Sasako M. For General Rules Committee of the Japanese Gastric Cancer Association. The new Japanese classification of Gastric Carcinoma: points to be revised. Gastric Cancer 1998; 1: 25–30.
14. Тер-Ованесов М.Д. Факторы прогноза хирургического лечения рака проксимального отдела желудка. Дис. ... д-ра мед. наук. М., 2007.
15. Hartgrink HH, van de Velde CJ, Putter H et al. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomized FAMTX trial. Eur J Surg Oncol 2004; 30: 643–9.
16. David Cunningham, William H Allum, Sally P. Stenning et al. for the MAGIC Trial: Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer NEJM, 2006; 355: 11–20.
17. Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725–30.
18. Sano T, Sasako M. For the Gastric Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG). Randomised controlled trial to evaluate para-aortic lymphadenectomy for gastric cancer (JCOG 9501). IVth International Gastric Cancer Congress, Abstructs, S 45: p. 663.
19. Sasako M. Extent of Lymphadenectomy in gastric Cancer: Have we Finally come to a Consensus? Gastrointestinal Cancer Symposium: multidisciplinary approaches to the prevention, diagnosis and therapy of GI Cancer, 2007; 39–41.
20. Ross P, Nicolson M, Cunningham D et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002; 20: 1996–2004.
Авторы
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.